Born in Kent, the daughter of Denis E. Bradley and Lillian (née Holder),[9] Carol Vivien Bradley left school at 16 and began her career as a lab technician in Sandwich, Kent with Pfizer, where she began working with the then novel technique of mass spectrometry.[10]
Her potential was spotted, and she gained further qualifications at evening classes and day release from her job at Pfizer. After earning her degree, she left Pfizer and studied for a Master of Science degree at the University of Swansea, followed by a Ph.D. at the University of Cambridge,[11] which she completed in just two years.[5] During this time she was a student at Churchill College, Cambridge.[2]
Robinson has broken ground as the first woman professor in the department of chemistry at both the University of Cambridge (2001) and the University of Oxford (2009).[14][third-party source needed] Her research has pushed the limits of electrospray ionization mass spectrometry, demonstrating that proteins and other complex macromolecules can be studied in the gas phase.[15] In addition to her contributions to the study of protein folding, Robinson has conducted important work on ribosomes, molecular chaperones and most recently membrane proteins.[16][17][18][19] Her research has made seminal contributions to gas-phase structural biology, with progress toward the study of protein complexes in their native environments for drug discovery.[20] Additionally, she is a co-founder of OMass Therapeutics, a University of Oxford spin-out company applying mass spectrometry technology to drug discovery.[21]
Distinguished for her research on the application of mass spectrometry to problems in chemical biology. She has used mass spectrometry to define the folding and binding of interacting proteins in large complexes. Most importantly, she has established that macromolecular complexes such as GroEL, ribosomes, and intact virus capsids can be generated in the gas phase and their electrospray mass spectra recorded. This work has demonstrated the power of mass spectrometry in studying very large complexes and allowed her to define changes in their conformation and the manner of their assembly.
In 2010 Robinson received the Davy Medal "for her ground-breaking and novel use of mass spectrometry for the characterisation of large protein complexes".[24][25]
In 2015 she was a laureate of the L'Oréal-UNESCO For Women in Science Awards; "For her groundbreaking work in macromolecular mass spectrometry and pioneering gas phase structural biology by probing the structure and reactivity of single proteins and protein complexes, including membrane proteins."[29]
In 2018 she won the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry from the American Chemical Society.[31]
In 2019 she won the Novozymes Prize for "almost single-handedly founding a subfield of mass spectrometry proteomics".[32] Also in 2019 she received the Royal Medal.[33]